19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Understanding the in vitro neuromuscular activity of snake venom Lys49 phospholipase A2 homologues.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Phospholipases A(2) (PLA(2)s) with a lysine substituting for the highly conserved aspartate 49, Lys49 PLA(2) homologues, are important myotoxic components in venoms from snakes of Viperidae family. These proteins induce conspicuous myonecrosis by a catalytically-independent mechanism. Traditionally, the Lys49 PLA(2) homologues are classified as non-neurotoxic myotoxins given their inability to cause lethality or paralytic effects when injected in vivo, even at relatively high doses. However, a series of in vitro studies has shown that several Lys49 PLA(2) homologues from Bothrops snake venoms induce neuromuscular blocking activity on nerve-muscle preparations in vitro. The interpretation of these findings has created some confusion in the literature, raising the question whether the Lys49 PLA(2) homologues present some neurotoxic activity. The present article reviews the in vitro neuromuscular effects of Lys49 PLA(2) homologues and discusses their possible mechanisms of action. It was concluded that the neuromuscular blockade induced by Lys49 PLA(2) homologues in isolated preparations is mainly a consequence of the general membrane-destabilizing effect of these toxins.

          Related collections

          Author and article information

          Journal
          Toxicon
          Toxicon : official journal of the International Society on Toxinology
          Elsevier BV
          1879-3150
          0041-0101
          Jan 2010
          : 55
          : 1
          Affiliations
          [1 ] Department of Pharmacology, Institute of Bioscience, São Paulo State University, Botucatu, São Paulo, Brazil. gallacci@ibb.unesp.br
          Article
          S0041-0101(09)00514-5
          10.1016/j.toxicon.2009.10.025
          19874839
          3c93aec8-5754-428f-89e9-b06ec8f6f37a
          History

          Comments

          Comment on this article